Diversified Capital Markets

UBS Group AG

UBS Global Wealth Management Downgrades European Tech Sector Rating to Neutral

UBS Cuts Asia ESG Team by Half as Part of Global Restructuring, Sustainability Workforce Shrinks

UBS Cuts Hundreds of EMEA Jobs to Integrate Credit Suisse, Aiming for $13.5B Savings by 2026

Hong Kong surpasses Switzerland to become global largest cross-border wealth center, UBS plans expansion

UBS Hosts 29th Asian Investment Forum Focusing on AI and Global Monetary Policy

UBS Group Receives Average 'Hold' Rating, Q3 EPS Beats Expectations

UBS moves EMEA wealth management head to Middle East after executive departure

Swiss Finance Minister Calls on UBS to Hold More Capital to Ensure Financial Stability

UBS Discloses Long Position in Qiagen, Holding Approx. 3.54M Shares Directly

UBS Report: US Leisure Air Travel Intentions Hold Steady Amidst Risks, Preference for Major Airlines Grows

UBS Report: AI-Driven Layoffs Rise to 16%, Significant Jump from Zero Last Year

Fed Terminates Enforcement Actions Against UBS and Credit Suisse Groups

Goldman Sachs Analyst Maintains UBS Holdings Rating

UBS Moves Headquarters to New Building Above West Kowloon Railway Station to Serve Greater Bay Area Clients

UBS Report: Enhanced Wealth Inheritance Awareness in Asia-Pacific

UBS Fined €6 Million by Monaco for Money-Laundering Control Violations

UBS CEO Emphasizes Expansion in US and Considers Relocation of Headquarters

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

Pinned News

置顶新闻

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 126,120 Shares of McKesson Corporation $MCK

UBS (UBS.US) Q1 2025 Earnings Conference Call

UBS (UBS.US) Q4 2024 Earnings Conference Call

UBS (UBS.US) Q3 2024 Earnings Conference Call

UBS AM reduced its McKesson (MCK) stake by 10.6% in Q4, selling 126,120 shares. Other hedge funds like Meiji Yasuda and LRI Investments increased their positions. Analysts maintain a 'Moderate Buy' consensus with a $960.53 target; UBS raised its target to $1,050. McKesson reported Q1 EPS of $11.69, beating estimates, though revenue missed. The company announced a dividend payment on July 1st.

Market Beat

McKesson

Bank of America

Deutsche Bank AG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

Geo Capital Gestora de Recursos Ltd increased its Moody's Corporation holdings by 4,109.1% in Q4, owning 4,630 shares valued at $2.37 million. Other institutional investors like CalPERS and Crossmark also boosted stakes. Analysts maintain a 'Moderate Buy' consensus with a $544.29 target price. Moody's recently reported Q1 EPS of $4.33, beating estimates, with revenue up 8.1% year-over-year.

Moodys

Berkshire Hathaway

Berkshire Hathaway B

Wells Fargo

Goldman Sachs

JPMorgan Chase

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

GS Hldg R

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Geo Capital Gestora de Recursos Ltd Raises Holdings in Moody's Corporation $MCO

UBS AM increased its Pfizer holdings by 4.4% in Q4, acquiring 1,517,551 shares to total 35.7 million shares valued at $889.3 million. Other investors like Horizon Financial also boosted positions. Analyst sentiment remains mixed; Zacks upgraded Pfizer to 'Hold', while others maintain neutral or underperform ratings with price targets around $26-$27. The stock trades near $26.19 with a consensus target of $28.82.

- UBS AM increased its holdings in Pfizer Inc. by 4.4%, owning 35,713,035 shares valued at approximately $889 million.  
- Other investors, including Horizon Financial Services and Godfrey Financial Associates, also enhanced their positions in Pfizer during the fourth quarter.  
- Analysts currently rate Pfizer around Hold, with a consensus target price of $28.82, reflecting mixed sentiments about its future growth amid concerns over cash flow and debt.

Pfizer

GlaxoSmithKline plc

Nuvalent

ROYAL BANK OF CANADA

Citigroup

GSK plc Sponsored ADR

CITIGROUP INC 6.250 NON CUM SER II PFD WI

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 1,517,551 Shares of Pfizer Inc. $PFE

UBER

UBEW

UBRL

UBS AM increased its stake in Uber Technologies by 2.0% in Q4, holding 13.08 million shares valued at $1.07 billion. Meanwhile, analyst ratings shifted with UBS downgrading to 'neutral' and TD Cowen initiating a 'hold', while Needham maintained a 'buy'. Uber recently reported Q1 EPS of $0.72, beating estimates, with revenue of $13.20 billion. Institutional ownership stands at 80.24%, and the consensus rating remains a 'Moderate Buy' with an average target price of $104.97.

Uber Tech

Roundhill UBER WeeklyPay ETF

GraniteShares 2x Long UBER Daily ETF

Alphabet

Alphabet - C

BNP Paribas

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Holdings in Uber Technologies, Inc. $UBER

UBS AM reduced its stake in Boston Scientific (BSX) by 0.4% in Q4, selling 41,428 shares to hold 10,936,957 shares valued at $1.04 billion. Other institutional investors like Brighton Jones and Ieq Capital increased their holdings. Insiders Edward J. Ludwig and David C. Habiger also purchased shares in May. Analysts maintain a 'Moderate Buy' consensus with an average target price of $85.08, though Leerink, Mizuho, and Raymond James recently lowered their price targets.

Boston Scientific

Raymond James Financial

Mizuho Financial

Mizuho Financial Group, Inc.

Piper Sandler Cos

Stifel Financial

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

STIFEL FINANCIAL CORP 6.125% DEP SHS REP 1/1000 NON CU PF SR C

Stifel Financial Pref Share SFB 5.2 10/15/47

STIFEL FINANCIAL CORP 6.25%NON CUM DEP SHS REP 1/1000TH SER B

STIFEL FINANCIAL CORP 4.50% DEP SHS REP 1/1000TH PREF SHS SR D

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 41,428 Shares of Boston Scientific Corporation $BSX

UBS AM increased its stake in Thermo Fisher Scientific (TMO) by 0.6% in Q4, holding 2.43 million shares valued at $1.4 billion. Other institutional investors, including Vanguard and Capital World Investors, also raised their positions. Meanwhile, TMO reported strong Q1 earnings, beating estimates with $5.44 EPS on $11.01 billion revenue. The company declared a $0.47 quarterly dividend and COO Gianluca Pettiti sold 400 shares under a pre-arranged plan.

Thermo Fisher Scentific

Franklin Resources

Morgan Stanley

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in Thermo Fisher Scientific Inc. $TMO

LIVN

Rhenman & Partners Asset Management AB increased its stake in LivaNova PLC by 258.5% in Q4, acquiring 137,000 shares to hold 190,000 valued at $11.69 million. Other institutions like Goldman Sachs and UBS also raised positions. Meanwhile, Director Francesco Bianchi sold 1,800 shares. LivaNova recently reported strong earnings, beating estimates with $0.98 EPS and $362.26M revenue. Analysts have adjusted price targets, with Needham raising theirs to $81.

Livanova

Barclays

Rhenman & Partners Asset Management AB Purchases 137,000 Shares of LivaNova PLC $LIVN

SNDK

SNDG

SNDQ

SNDU

SNXX

Caitong International Asset Management reduced its Sandisk (SNDK) holdings by 93.6% in Q4, leaving 280 shares valued at $66,000. Conversely, UBS AM and Wells Fargo increased their positions. Analysts raised price targets, with Bank of America setting a $2,100 target and Susquehanna $3,250, maintaining a consensus 'Moderate Buy' rating. Additionally, insiders Bernard Shek and Alper Ilkbahar sold shares in early June under pre-arranged plans.

Sandisk

Leverage Shares 2X Long SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

T-REX 2X Long SNDK Daily Target ETF

Tradr 2X Long Sndk Daily ETF

Micron Tech

Sandisk - WI

Sandisk Corporation $SNDK Shares Sold by Caitong International Asset Management Co. Ltd

SGOL

GLDM

518850

USDU

UBS has lowered its near-term gold price target to $3,850–$4,000, citing pressure from a stronger U.S. dollar and Federal Reserve rate-hike expectations. Gold has entered a bear market, falling over 25% from January's record. Despite the short-term weakness, UBS remains positive on gold for the next year, supported by sustained central bank buying and potential dollar depreciation.

SPDR Gold Shares

Abrdn Gold ETF Trust

SPDR Gold Minishares

Pro Ultr GLD

ETFS Capital Ltd.

ChinaAMC Gold ETF

Wtree Bbg Usd Bull

iShares Gold Trust

Invesco DB US Dollar Index Bullish Fund

UBS cuts gold target as Fed outlook pressures prices

On June 11, 2026, UBS Asset Management disclosed a Form 8.3 regarding its interests in EasyJet PLC. As of June 10, 2026, UBS held 24,947,117 ordinary shares, representing 3.29% of the company. The disclosure also details a sale of 61,219 shares at 4.756 GBP per unit. No short positions, derivatives, or other dealing arrangements were reported.

London Stock Exchange

easyJet plc

easyJet

REG - UBS Asset Management easyJet PLC - Form 8.3 - EASYJET PLC

UBS Asset Management disclosed its holding in DCC PLC on June 12, 2026. As of June 11, UBS held 3,001,648 shares, representing a 3.51% interest, with no short positions. The disclosure also details recent dealings: purchases of 14,977 shares and sales of 2,040 shares, both at €61.3 GBP per unit.

DCC Plc

REG - UBS Asset Management DCC PLC - Form 8.3 - DCC PLC

UBS Group AG(UBS.US)